Table of Content

1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Introduction and Overview
1.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Manufacturer
2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Manufacturer
2.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price by Manufacturers
2.4 Manufacturers Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Production Sites, Area Served, Product Type
2.5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Competitive Situation and Trends
2.5.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.5.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Sanofi S.A.
3.1.1 Sanofi S.A. Company Profile
3.1.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.1.3 Sanofi S.A. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.1.4 Sanofi S.A. Business Overview
3.2 Reckitt Benckiser Group PLC
3.2.1 Reckitt Benckiser Group PLC Company Profile
3.2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.2.3 Reckitt Benckiser Group PLC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.2.4 Reckitt Benckiser Group PLC Business Overview
3.3 Pfizer Inc.
3.3.1 Pfizer Inc. Company Profile
3.3.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.3.3 Pfizer Inc. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.3.4 Pfizer Inc. Business Overview
3.4 GlaxoSmithKline Plc
3.4.1 GlaxoSmithKline Plc Company Profile
3.4.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.4.3 GlaxoSmithKline Plc Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.4.4 GlaxoSmithKline Plc Business Overview
3.5 Sun Pharmaceutical Industries Ltd
3.5.1 Sun Pharmaceutical Industries Ltd Company Profile
3.5.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.5.3 Sun Pharmaceutical Industries Ltd Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.5.4 Sun Pharmaceutical Industries Ltd Business Overview
3.6 Assertio Therapeutics, Inc.
3.6.1 Assertio Therapeutics, Inc. Company Profile
3.6.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.6.3 Assertio Therapeutics, Inc. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.6.4 Assertio Therapeutics, Inc. Business Overview
3.7 Johnson & Johnson
3.7.1 Johnson & Johnson Company Profile
3.7.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.7.3 Johnson & Johnson Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.7.4 Johnson & Johnson Business Overview
3.8 Bayer AG
3.8.1 Bayer AG Company Profile
3.8.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.8.3 Bayer AG Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.8.4 Bayer AG Business Overview
3.9 Horizon Therapeutics plc
3.9.1 Horizon Therapeutics plc Company Profile
3.9.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.9.3 Horizon Therapeutics plc Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.9.4 Horizon Therapeutics plc Business Overview
3.10 Iroko Pharmaceuticals Inc.
3.10.1 Iroko Pharmaceuticals Inc. Company Profile
3.10.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
3.10.3 Iroko Pharmaceuticals Inc. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
3.10.4 Iroko Pharmaceuticals Inc. Business Overview
4 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historical and Forecast Market Analysis by Type
4.1 Market Size Analysis by Types
4.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Type
4.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Type
4.4 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast by Type (2024-2030)
4.5 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Forecast by Type (2024-2030)
5 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historical and Forecast Market Analysis by Application
5.1 Market Size Analysis by Application
5.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2019-2024)
5.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2019-2024)
5.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast by Application (2024-2030)
5.5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Forecast by Application (2024-2030)
6 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Production Growth Trends Analysis
6.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size & Forecast (2019-2030)
6.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends Analysis by Regions
6.2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Production Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Regions (2019-2024)
6.2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2024-2030)
6.2.4 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Production & Forecast (2019-2030)
6.2.5 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Production & Forecast (2019-2030)
6.2.6 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Production & Forecast (2019-2030)
6.2.7 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Production & Forecast (2019-2030)
6.2.8 Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Production & Forecast (2019-2030)
6.2.9 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Production & Forecast (2019-2030)
6.2.10 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Production & Forecast (2019-2030)
6.2.11 South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Production & Forecast (2019-2030)
6.2.12 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Production & Forecast (2019-2030)
7 Global Market Growth Trends Analysis
7.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size & Forecast (2019-2030)
7.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends Analysis by Regions
7.2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Market Size by Regions: 2019 VS 2024 VS 2030
7.2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Regions (2019-2024)
7.2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2024-2030)
7.2.4 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption & Forecast (2019-2030)
7.2.5 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption & Forecast (2019-2030)
7.2.6 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption & Forecast (2019-2030)
7.2.7 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption & Forecast (2019-2030)
7.2.8 Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption & Forecast (2019-2030)
7.2.9 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption & Forecast (2019-2030)
7.2.10 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption & Forecast (2019-2030)
7.2.11 South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption & Forecast (2019-2030)
7.2.12 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption & Forecast (2019-2030)
8 North America
8.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Types
8.2 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Applications
8.3 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption, Price, Revenue, Gross and Gross Margin (2019-2024)
9 Europe
9.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Types
9.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Applications
9.3 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption, Price, Revenue, Gross and Gross Margin (2019-2024)
10 China
10.1 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Types
10.2 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Applications
10.3 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption, Price, Revenue, Gross and Gross Margin (2019-2024)
11 Japan
11.1 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Types
11.2 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Applications
11.3 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption, Price, Revenue, Gross and Gross Margin (2019-2024)
12 Korea
12.1 Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Types
12.2 Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Applications
12.3 Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption, Price, Revenue, Gross and Gross Margin (2019-2024)
13 Southeast Asia
13.1 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Types
13.2 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Applications
13.3 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption, Price, Revenue, Gross and Gross Margin (2019-2024)
14 India
14.1 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Types
14.2 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Applications
14.3 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption, Price, Revenue, Gross and Gross Margin (2019-2024)
15 South America
15.1 South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Types
15.2 South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Applications
15.3 South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption, Price, Revenue, Gross and Gross Margin (2019-2024)
16 Middle East & Africa
16.1 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Types
16.2 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Applications
16.3 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption, Price, Revenue, Gross and Gross Margin (2019-2024)
17 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturing Cost Analysis
17.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.1.2 Price Trend of Key Raw Materials
17.1.3 Key Suppliers of Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.2.1 Raw Materials
17.2.2 Labor Cost
17.2.3 Manufacturing Expenses
17.3 Manufacturing Process Analysis of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
17.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industrial Chain Analysis
18 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Dynamic Analysis
18.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends Analysis
18.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers Analysis
18.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges Analysis
18.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints Analysis
18.5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Technology Analysis
19 Market Channel, Distributors, Traders and Dealers
19.1 Market Channel Status
19.1.1 Direct Marketing
19.1.2 Indirect Marketing
19.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Typical Distributors
19.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Typical Customers
20 Research Findings and Conclusion